Geode Capital Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.41M Sell
50,942
-454,509
-90% -$12.6M ﹤0.01% 3233
2025
Q1
$11.2M Buy
505,451
+12,821
+3% +$285K ﹤0.01% 2216
2024
Q4
$9.74M Buy
492,630
+9,654
+2% +$191K ﹤0.01% 2398
2024
Q3
$12.1M Sell
482,976
-365,918
-43% -$9.14M ﹤0.01% 2270
2024
Q2
$15.8M Buy
848,894
+123,383
+17% +$2.29M ﹤0.01% 2058
2024
Q1
$14.3M Buy
725,511
+25,898
+4% +$511K ﹤0.01% 2114
2023
Q4
$12.3M Buy
699,613
+40,044
+6% +$702K ﹤0.01% 2222
2023
Q3
$11.5M Buy
659,569
+46,917
+8% +$815K ﹤0.01% 2178
2023
Q2
$8.63M Buy
612,652
+43,323
+8% +$610K ﹤0.01% 2375
2023
Q1
$6.13M Buy
569,329
+24,992
+5% +$269K ﹤0.01% 2543
2022
Q4
$8.15M Buy
544,337
+20,864
+4% +$313K ﹤0.01% 2391
2022
Q3
$6.72M Sell
523,473
-7,996
-2% -$103K ﹤0.01% 2512
2022
Q2
$5.15M Buy
531,469
+12,175
+2% +$118K ﹤0.01% 2685
2022
Q1
$5.16M Sell
519,294
-13,923
-3% -$138K ﹤0.01% 2781
2021
Q4
$6.28M Buy
533,217
+56,822
+12% +$669K ﹤0.01% 2763
2021
Q3
$5.43M Buy
476,395
+17,536
+4% +$200K ﹤0.01% 2863
2021
Q2
$6.39M Buy
458,859
+35,950
+9% +$501K ﹤0.01% 2754
2021
Q1
$7.83M Buy
422,909
+44,427
+12% +$822K ﹤0.01% 2522
2020
Q4
$6.69M Buy
378,482
+31,593
+9% +$558K ﹤0.01% 2423
2020
Q3
$5.31M Buy
346,889
+111,903
+48% +$1.71M ﹤0.01% 2362
2020
Q2
$5.99M Buy
234,986
+30,837
+15% +$786K ﹤0.01% 2228
2020
Q1
$3.16M Buy
204,149
+13,631
+7% +$211K ﹤0.01% 2422
2019
Q4
$2.11M Buy
190,518
+24,617
+15% +$272K ﹤0.01% 2972
2019
Q3
$1.41M Buy
165,901
+3,792
+2% +$32.3K ﹤0.01% 3105
2019
Q2
$2.19M Buy
162,109
+12,013
+8% +$163K ﹤0.01% 2896
2019
Q1
$2.71M Buy
150,096
+53,345
+55% +$963K ﹤0.01% 2675
2018
Q4
$2.72M Sell
96,751
-372
-0.4% -$10.4K ﹤0.01% 2587
2018
Q3
$2.48M Buy
+97,123
New +$2.48M ﹤0.01% 2775